To provide important clinical data on the management of hepatic encephalopathy.
This activity has been designed to meet the educational needs of gastroenterologists, hepatologists, physician assistants, and nurse practitioners involved in the care of patients with chronic liver disease.
Statement of Need/Program Overview
The goal of this program is to improve healthcare providers competency in understanding the long-term effects and potential liver related complications of chronic liver diseases. The program will also provide education on management options and outcomes of treatment.
Upon completion of this activity, participants should be better able to:
Assess the benefits of primary prophylactic therapy for cirrhotic patients with covert hepatic encephalopathy and of secondary prophylactic therapy for patients who have recovered from an overt hepatic encephalopathy episode
Evaluate data that suggest cognitive impairment following an episode of overt hepatic encephalopathy may not be completely reversible and that impairment from recurrent episodes of hepatic encephalopathy may be cumulative
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University School of Pharmacy and the Chronic Liver Disease Foundation (CLDF). Purdue University School of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.
Purdue University College of Pharmacy designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Faculty Disclosure Statement
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.
Americans with Disabilities Act
The event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.). Please contact us prior to the event at 888-582-4532.
Jointly sponsored by Purdue University College of Pharmacy and the Chronic Liver Disease Foundation.
This activity supported by:
Salix Pharmaceuticals, Inc.